Healthcare provider profile · identity verified

Robert Barnett, CNP

Nurse Practitioner · CINCINNATI, OH · NPI 1902474992

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	544	171
Lisinopril	Lisinopril	382	114
Levothyroxine Sodium	Levothyroxine Sodium	370	122
Amlodipine Besylate	Amlodipine Besylate	347	113
Omeprazole	Omeprazole	237	76
Pantoprazole Sodium	Pantoprazole Sodium	224	73
Hydrochlorothiazide	Hydrochlorothiazide	211	63
Rosuvastatin Calcium	Rosuvastatin Calcium	204	71
Metoprolol Succinate	Metoprolol Succinate	165	59
Montelukast Sodium	Montelukast Sodium	161	51
Losartan Potassium	Losartan Potassium	147	53
Albuterol Sulfate Hfa	Albuterol Sulfate	139	53
Escitalopram Oxalate	Escitalopram Oxalate	127	38
Furosemide	Furosemide	124	45
Trazodone Hcl	Trazodone Hcl	122	33
Metformin Hcl	Metformin Hcl	112	34
Eliquis	Apixaban	109	23
Metformin Hcl Er	Metformin Hcl	106	38
Tamsulosin Hcl	Tamsulosin Hcl	98	33
Metoprolol Tartrate	Metoprolol Tartrate	93	27
Meloxicam	Meloxicam	90	33
Potassium Chloride	Potassium Chloride	90	33
Trulicity	Dulaglutide	89	23
Simvastatin	Simvastatin	87	30
Alendronate Sodium	Alendronate Sodium	79	24
Bupropion Xl	Bupropion Hcl	77	23
Ezetimibe	Ezetimibe	77	23
Fluticasone Propionate	Fluticasone Propionate	75	28
Allopurinol	Allopurinol	74	29
Synthroid	Levothyroxine Sodium	74	29
Glimepiride	Glimepiride	70	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	21
Januvia	Sitagliptin Phosphate	67	18
Sertraline Hcl	Sertraline Hcl	65	19
Methylprednisolone	Methylprednisolone	64	57
Clopidogrel	Clopidogrel Bisulfate	62	17
Atenolol	Atenolol	61	21
Tizanidine Hcl	Tizanidine Hcl	60	27
Ropinirole Hcl	Ropinirole Hcl	59	19
Famotidine	Famotidine	58	22
Farxiga	Dapagliflozin Propanediol	58	17
Citalopram Hbr	Citalopram Hydrobromide	49	16
Gabapentin	Gabapentin	47	16
Venlafaxine Hcl Er	Venlafaxine Hcl	46	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	16
Azithromycin	Azithromycin	44	41
Lovastatin	Lovastatin	44	11
Xarelto	Rivaroxaban	44	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	12
Fenofibrate	Fenofibrate Nanocrystallized	43	17
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Cefdinir	Cefdinir	41	39
Duloxetine Hcl	Duloxetine Hcl	40	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	38	35
Carvedilol	Carvedilol	38	16
Pravastatin Sodium	Pravastatin Sodium	37	13
Buspirone Hcl	Buspirone Hcl	36	11
Ventolin Hfa	Albuterol Sulfate	36	11
Hydralazine Hcl	Hydralazine Hcl	34	11
Olmesartan Medoxomil	Olmesartan Medoxomil	34	12
Warfarin Sodium	Warfarin Sodium	34	13
Lorazepam	Lorazepam	33	12
Benazepril Hcl	Benazepril Hcl	32	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	13
Mirtazapine	Mirtazapine	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	12
Jardiance	Empagliflozin	31	13
Hydroxyzine Hcl	Hydroxyzine Hcl	30	11
Ondansetron Hcl	Ondansetron Hcl	30	15
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Liothyronine Sodium	Liothyronine Sodium	28	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	26
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	21
Ozempic	Semaglutide	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Prednisone	Prednisone	23	21
Clonazepam	Clonazepam	22	11
Clonidine Hcl	Clonidine Hcl	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	12
Glipizide	Glipizide	21	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Amoxicillin	Amoxicillin	17	17
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Fluconazole	Fluconazole	17	16
Lansoprazole	Lansoprazole	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	13
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Valsartan	Valsartan	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Finasteride	Finasteride	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Vraylar	Cariprazine Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Linzess	Linaclotide	13	suppressed
Nystatin	Nystatin	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Sucralfate	Sucralfate	12	suppressed
Viibryd	Vilazodone Hcl	12	suppressed
Primidone	Primidone	11	suppressed
Roflumilast	Roflumilast	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error